Dreamgard, Inc. Announces First FDA-Cleared Prescription Dental Night guard Designed to Treat Bruxis

·        60 million people suffer from bruxism in the U.S.  Research shows that fewer than 20 percent receive treatment due to a lack of education on the disorder, high treatment cost and treatment ineffectiveness.


·        FDA clearance allows Dreamgard to make medical claims of teeth protection, short-term pain relief and prevention of TMJ syndrome, and provides the patient and dental practice with an assurance of quality, safety and effectiveness.


·        With FDA clearance, Dreamgard can brand, market and advertise, providing patients with education on bruxism and the benefits of the Dreamgard solution.



·        Patient compliance (the key to relief) is extremely high with Dreamgard, due to its incredibly thin and comfortable soft/hard multi-layer design.



·        Dreamgard’s unique in-mouth equilibration process saves valuable chair time and doctor time by requiring only an upper impression and eliminating the need for fitting or adjustment.



·        Dreamgard’s streamlined process allows its night guards to be priced more affordably to the patient ($299 suggested patient price).


·        Dreamgard is an effective practice builder that can generate significant incremental revenue for the practice.

Dreamgard night guards are sold only through licensed dentist in the U.S.

More information on bruxism and the Dreamgard solution can be found at www.dreamgard.com